Expert Advice on Hypertension Management in Counties in the Context of SARS-CoV-2 Infection

doi:10.12114/j.issn.1007-9572.2020.00.303

Abstract

Abstract: At present，epidemics of Corona Virus Disease 2019(COVID-19) have occurred in Wuhan，provinces across China，and overseas countries.Aiming at the large group of patients with hypertension in China，especially those distributed at the grassroots level，expert advice on hypertension management in the context of COVID-19 is proposed.This guidance is limited to patients with hypertension who do not have the SARS-CoV-2 infection.

Key words: Novel coronavirus pneumonia, COVID-19, Severe acute respiratory syndrome coronavirus 2, Hypertension, Chronic disease management

摘要： 目前，我国各省份及境外均出现了新型冠状病毒（SARS-CoV-2）感染疫情。针对我国庞大的高血压患者群体，尤其是更多分布于基层的高血压患者，现提出县域SARS-CoV-2感染下的高血压管理的专家建议。本建议仅限于没有合并SARS-CoV-2感染的高血压患者。

关键词: 新型冠状病毒感染, 新型冠状病毒所致的疾病, 严重急性呼吸综合征冠状病毒2, 高血压, 慢病管理

Hypertension Group，Professional Committee for Chronic Disease. Expert Advice on Hypertension Management in Counties in the Context of SARS-CoV-2 Infection　[J]. Chinese General Practice, 2020, 23(7): 770-773.

县域医院院长联盟慢病管理专业委员会高血压学组. 新型冠状病毒感染疫情下县域高血压管理的专家建议[J]. 中国全科医学, 2020, 23(7): 770-773.

References

［1］WANG C，HORNBY P W，HAYDEN F G，et al．A novel coronavirus outbreak of global health concern［J］．Lancet，2020．［Epub ahead of print］．DOI：10.1016/S0140-6736(20)30185-9.
［2］MADJID M，SOLOMON S D，VARDENY O，et al．ACC clinical bulletin：cardiac implications of novel Wuhan coronavirus（2019-nCoV）［R］．Washington：ACC，2020.
［3］HUANG C，WANG Y，LI X，et al．Clinical features of patients infected with 2019 novel coronavirus in Wuhan，China［J］.Lancet，2020，395（10223）：497-506．DOI：10.1016/S0140-6736(20)30183-5.
［4］王超群.新冠肺炎对我国分级诊疗制度建设的启示［EB/OL］.（2020-02-17）［2020-02-20］.http://www.cssn.cn/zx/bwyc/202002/t20200217_5089128.shtml.
［5］中国疾病预防控制中心新型冠状病毒肺炎应急响应机制流行病学组．COVID-19流行病学特征分析［J］.中华流行病学杂志，2020，41（2）：145-151．DOI：10.3760/cma.j.issn.0254-6450.2020.02.003．
Epidemiology Working Group for NCIP Epidemic Response.The epidemiological characteristies of an outbreak of 2019 novel coronavirus diseases（COVID-19） in China［J］.Chin J Epidemiol，2020，41（2）：145-151．DOI：10.3760/cma.j.issn.0254-6450.2020.02.003.
［6］GUO L，WEI D，ZHANG X，et al．Clinical features predicting mortality risk in patients with viral pneumonia：the MuLBSTA score［J］．Front Microbiol，2019，10：2752．DOI：10.3389/fmicb.2019.02752.
［7］李媛．新型肺炎80例死亡病例，透露了什么关键信息？
［EB/OL］.（2020-01-27）［2020-02-20］．http://www.bjnews.com.cn/graphic/2020/01/27/680478.html.
［8］XU X，CHEN P，WANG J，et al．Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission［J］．Sci China Life Sci，2020．［Epub ahead of print］．DOI：10.1007/s11427-020-1637-5.
［9］陈云新，秦川．ACE2在SARS发病中作用的研究进展［J］．中国实验动物学报，2008，16（3）：229-232.
CHEN Y X，QIN C．Progress in research on the role of ACE2 in SARS pathogenesis［J］．Acta Laboratorium Animalis Scientia Sinica，2008，16（3）：229-232.
［10］ZHAO Y，ZHAO Z X，WANG Y J，et al．Single-cell RNA expression profiling of ACE2，the putative receptor of Wuhan 2019-nCov［J］．Biorixv，2020．［Epub ahead of print］．DOI：10.1101/2020.01.26.919985.
［11］ ZHOU P，YANG X L，WANG X G，et al．A pneumonia outbreak associated with a new coronavirus of probable bat origin［J］.Nature，2020．［Epub ahead of print］．DOI：10.1038/s41586-020-2012-7.
［12］杨震，于欣，贾绍斌，等．ACE2和ACE在自发性高血压大鼠心肌中的变化［J］．临床心血管病杂志，2011，27（12）：914-917．DOI：10.3969/j.issn.1001-1439.2011.12.011.
YANG Z，YU X，JIA S B，et al．Cardiac expression of angiotensin-converting enzyme 2 and angiotensin-converting enzyme in spontaneously hypertensive rats［J］．Journal of Clinical Cardiology，2011，27（12）：914-917．DOI：10.3969/j.issn.1001-1439.2011.12.011.
［13］中国高血压联盟《家庭血压监测指南》委员会.2019中国家庭血压监测指南［J］.中国循环杂志，2019，34（7）：635-639．DOI：10.3969/j.issn.1000-3614.2019.07.003.
Home Blood Pressure Monitoring Guideline Committee of the Chinese Hypertension League．2019 Chinese hypertension league guideline on home blood pressure monitoring［J］．Chinese Circulation Journal，2019，34（7）：635-639．DOI：10.3969/j.issn.1000-3614.2019.07.003.
［14］中国高血压防治指南修订委员会，高血压联盟（中国），中华医学会心血管病学分会中国医师协会高血压专业委员会，等．中国高血压防治指南（2018年修订版）［J］.中国心血管杂志，2019，24（1）：24-56．DOI：10.3969/j.issn.1007-5410.2019.01.002.http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zgxxgzz201901002.

[1]	ZHANG Shuai, LI Qin, LI Dongfeng, XIAO Jinping, LI Yunpeng. A Prospective Cohort Study of Solid Fuels Use and Risk of Hypertension in Chinese Older Adults [J]. Chinese General Practice, 2023, 26(32): 4001-4006.
[2]	XIAO Liqi, YANG Li, CUI Saixian, ZHANG Yayuan, WANG Yulu, HE Yan. Advances in the Association of High Salt-induced Gut Microbiota Disturbances with Salt-sensitive Blood Pressure [J]. Chinese General Practice, 2023, 26(29): 3704-3709.
[3]	CHENG Xiaoran, ZHANG Xiaotian, LI Mingyue, CHENG Haozhe, TANG Haoqing, ZHENG Huixian, ZHANG Baisong, LIU Xiaoyun. Impact of Chronic Diseases Follow-up on Health Behaviors and Blood Pressure/Glucose Control of Patients with Hypertension and Diabetes in the Context of Treatment-prevention Integration [J]. Chinese General Practice, 2023, 26(28): 3482-3488.
[4]	BIAN Lili, LI Xiaoxiao, DU Xueping, DAI Qinfang, WU Lin, SONG Beibei. Risk Stratification of Atherosclerotic Cardiovascular Disease and Lipid Goal Attainment in Hypertensive Patients Registered in Community [J]. Chinese General Practice, 2023, 26(27): 3388-3391.
[5]	ZHAO Wei, TANG Rongjie, YANG Shanshan, YANG Fang, SUN Feng, LIAN Qiufang. The Role and Molecules Mechanism of Klotho in Renal Injury in Salt-sensitive Hypertension [J]. Chinese General Practice, 2023, 26(24): 3042-3049.
[6]	ZUO Xu, HUANG Zhaolan, LU Biao. Differences between the First and Another 3-day Blood Pressure Levels and Associated Factors in a Self-reported Non-hypertensive Population Aged 35-64 Years [J]. Chinese General Practice, 2023, 26(22): 2771-2777.
[7]	WU Jian, YU Chengcheng, YANG Yinmei, XIA Qingyun, LI Quanman, FU Xiaoli. COVID-19 Vaccination Behavior and Its Influencing Factors among the Elderly in Four Regions of China [J]. Chinese General Practice, 2023, 26(22): 2763-2770.
[8]	FENG Jia, WANG Jie, YU Dan, LIU Yongheng, ZHAO Weidong, TIAN Hongyuan. Analysis of Research Hotspots of Multiple Chronic Conditions in the Elderly in 2010-2021 [J]. Chinese General Practice, 2023, 26(21): 2574-2580.
[9]	HE Mei, LI Hui, MU Lifeng, YANG Ming. Effect of Azovudine on Hepatic and Renal Function in Patients with COVID-19: a Case Series Study [J]. Chinese General Practice, 2023, 26(20): 2476-2481.
[10]	FEI Min, LEI Si, XU Yan, YE Yun, ZHUO Hui, ZHANG Hui, LUO Yingquan. Association of Obstructive Sleep Apnea-hypopnea Syndrome with Blood Pressure Variability and Heart Rate Variability in Patients with Hypertension [J]. Chinese General Practice, 2023, 26(20): 2459-2468.
[11]	YU Tong, YANG Yi, DU Shihong, DING Zihao, HONG Xiuqin. Correlation of Shearing Force and Estradiol with Hypertension [J]. Chinese General Practice, 2023, 26(20): 2469-2475,2495.
[12]	TIAN Meixiang, ZHANG Zhengyi. Standard Management of Hypertension During the Preparation for Pregnancy [J]. Chinese General Practice, 2023, 26(18): 2190-2194.
[13]	LIU Hai, HUANG Guanhua. The Significance of High Normal Blood Pressure for Children and Adolescents [J]. Chinese General Practice, 2023, 26(18): 2183-2189.
[14]	WANG Hai, WANG Zhuoli, PEI Honghong, PAN Longfei. Analysis of Risk Factors and Exploration of Predictors of Serious Cases of COVID-19 in Xi'an during the Period of 2021-2022 [J]. Chinese General Practice, 2023, 26(17): 2132-2137.
[15]	YAN Yuge, HUANG Jiaoling. Visualization Analysis of Primary Healthcare Research during the COVID-19 Pandemic [J]. Chinese General Practice, 2023, 26(16): 2027-2035.